Gauri G. Rao

2.4k total citations · 1 hit paper
102 papers, 1.6k citations indexed

About

Gauri G. Rao is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Gauri G. Rao has authored 102 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Medicine, 51 papers in Pharmacology and 29 papers in Epidemiology. Recurrent topics in Gauri G. Rao's work include Antibiotic Resistance in Bacteria (62 papers), Antibiotics Pharmacokinetics and Efficacy (49 papers) and Pneumonia and Respiratory Infections (18 papers). Gauri G. Rao is often cited by papers focused on Antibiotic Resistance in Bacteria (62 papers), Antibiotics Pharmacokinetics and Efficacy (49 papers) and Pneumonia and Respiratory Infections (18 papers). Gauri G. Rao collaborates with scholars based in United States, Australia and Brazil. Gauri G. Rao's co-authors include Jian Li, Roger L. Nation, Cornelia B. Landersdorfer, Alan Forrest, Phillip J. Bergen, Neang S. Ly, Brian T. Tsuji, Keith S. Kaye, Tony Velkov and Jürgen B. Bulitta and has published in prestigious journals such as Cell, PLoS ONE and Scientific Reports.

In The Last Decade

Gauri G. Rao

94 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacokinetics/pharmacodynamics of phage therapy: a major hurdle to clinical translation

2023 85 citations Sue C. Nang, Gauri G. Rao et al. Clinical Microbiology and Infection profile →

Peers

Countries citing papers authored by Gauri G. Rao

Since Specialization

Citations

This map shows the geographic impact of Gauri G. Rao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gauri G. Rao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gauri G. Rao more than expected).

Fields of papers citing papers by Gauri G. Rao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gauri G. Rao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gauri G. Rao. The network helps show where Gauri G. Rao may publish in the future.

Co-authorship network of co-authors of Gauri G. Rao

This figure shows the co-authorship network connecting the top 25 collaborators of Gauri G. Rao. A scholar is included among the top collaborators of Gauri G. Rao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gauri G. Rao. Gauri G. Rao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genomic insights of two Acinetobacter non-baumannii strains with uncommon mechanisms of resistance leading to cefiderocol resistance 2025 ·Infection Genetics and Evolution ·(unknown), (unknown), (unknown), Juan Pablo Gutiérrez, Fernando Pasterán, Marisel R. Tuttobene, (unknown), Jerry C. Cheng, (unknown), Rajnikant Sharma, Marcelo E. Tolmasky, Gauri G. Rao, Robert A. Bonomo, Germán M. Traglia, María Soledad	0
2	A novel role for colistin as an efflux pump inhibitor in multidrug-resistant Klebsiella pneumoniae 2025 ·Scientific Reports ·Rajnikant Sharma, (unknown), (unknown), Vincenzo Carbone, Leslie M. Hicks, Bruce E. Blough, Tony Velkov, Gauri G. Rao	1
3	Spontaneous Emergence of Cefiderocol Resistance in Klebsiella pneumoniae KPC-163: Genomic and Transcriptomic Insights 2025 ·Antibiotics ·(unknown), (unknown), (unknown), Germán M. Traglia, Marisel R. Tuttobene, María Cecilia Rodríguez, (unknown), (unknown), Rajnikant Sharma, Marcelo E. Tolmasky, Robert A. Bonomo, Gauri G. Rao, Fernando Pasterán, María Soledad Ramírez	0
4	A mechanism-based pharmacokinetic/pharmacodynamic analysis of polymyxin B-based combination therapy against carbapenem-resistant Klebsiella pneumoniae isolates with diverse phenotypic and genotypic resistance mechanisms 2025 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), Rajnikant Sharma, Hongqiang Qiu, Ahmed Elsheikh, (unknown), Cely Saad Abboud, Fernando Pasterán, María Soledad Ramírez, Keith S. Kaye, Robert A. Bonomo, Gauri G. Rao	0
5	Emerging resistance to novel β-lactam β-lactamase inhibitor combinations in Klebsiella pneumoniae bearing KPC variants 2025 ·Journal of Global Antimicrobial Resistance ·(unknown), Germán M. Traglia, (unknown), Sonia Gómez, (unknown), (unknown), (unknown), (unknown), (unknown), María Cecilia Rodríguez, Christopher R. Bethel, Gauri G. Rao, Marcelo E. Tolmasky, David Paterson, Robert A. Bonomo, Fernando Pasterán, María Soledad	1
6	Insights into Acinetobacter baumannii AMA205’s Unprecedented Antibiotic Resistance 2024 ·International Journal of Molecular Sciences ·Germán M. Traglia, Fernando Pasterán, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Marisel R. Tuttobene, (unknown), C. Ferro Fontán, Ezequiel Albornoz, (unknown), Robert A. Bonomo, Gauri G. Rao, Marcelo E. Tolmasky, María Soledad Ramírez	2
7	Phage resistance in Klebsiella pneumoniae and bidirectional effects impacting antibiotic susceptibility 2024 ·Clinical Microbiology and Infection ·Sue C. Nang, Jing Lü, Heidi H. Yu, (unknown), Mohammad Abul Kalam Azad, Mei‐Ling Han, Jinxin Zhao, Gauri G. Rao, Phillip J. Bergen, Tony Velkov, Norelle L. Sherry, David McCarthy, Saima Aslam, Robert T. Schooley, Benjamin P. Howden, Jeremy J. Barr, Yan Zhu, Jian Li	11
8	Proof‐of‐concept for incorporating mechanistic insights from multi‐omics analyses of polymyxin B in combination with chloramphenicol against Klebsiella pneumoniae 2023 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), (unknown), Rajnikant Sharma, (unknown), Stacey D. Finley, Phillip J. Bergen, Tony Velkov, Jian Li, Gauri G. Rao	3
9	Pharmacokinetic Considerations for Optimizing Inhaled Spray-Dried Pyrazinoic Acid Formulations 2023 ·Molecular Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Victoria K. Baxter, Elizabeth J. Anderson, (unknown), (unknown), (unknown), Ian E. Stewart, Miriam Braunstein, Anthony J. Hickey, Gauri G. Rao	2
10	Integrated Transcriptomic and Metabolomic Mapping Reveals the Mechanism of Action of Ceftazidime/Avibactam against Pan-Drug-Resistant Klebsiella pneumoniae 2023 ·ACS Infectious Diseases ·Maytham Hussein, (unknown), Jinxin Zhao, Heidi H. Yu, Stephanie L. Neville, Jonathan J. Wilksch, (unknown), Mark A. Baker, Christopher A. McDevitt, Gauri G. Rao, Jian Li, Tony Velkov	3
11	A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections 2022 ·Antimicrobial Agents and Chemotherapy ·Courtney Luterbach, Hongqiang Qiu, (unknown), Rajnikant Sharma, Joseph Piscitelli, Feng‐Chang Lin, Jenni Ilomäki, Eric Cober, Robert A. Salata, Robert C. Kalayjian, Richard Watkins, Yohei Doi, Keith S. Kaye, Roger L. Nation, Robert A. Bonomo, Cornelia B. Landersdorfer, David van Duin, Gauri G. Rao	12
12	Clinical challenges treatingStenotrophomonas maltophiliainfections: an update 2022 ·JAC-Antimicrobial Resistance ·María F. Mojica, Romney M. Humphries, John J. LiPuma, Amy J. Mathers, Gauri G. Rao, Samuel A. Shelburne, Derrick E. Fouts, David van Duin, Robert A. Bonomo	72
13	Pharmacodynamic and immunomodulatory effects of polymyxin B in combination with fosfomycin against KPC-2-producing Klebsiella pneumoniae 2022 ·International Journal of Antimicrobial Agents ·Rajnikant Sharma, (unknown), (unknown), (unknown), Faisal S. Minhaj, (unknown), Evelyn J. Ellis‐Grosse, Cely Saad Abboud, Gauri G. Rao	9
14	Knowledge dissemination and central indexing of resources in pharmacometrics: an ISOP education working group initiative 2022 ·Journal of Pharmacokinetics and Pharmacodynamics ·Eleni Karatza, T. V. Yakovleva, (unknown), Gauri G. Rao, Sihem Ait‐Oudhia	1
15	Insights Into Patient Variability During Ivacaftor-Lumacaftor Therapy in Cystic Fibrosis 2021 ·Frontiers in Pharmacology ·(unknown), Isabelle Sermet‐Gaudelus, Matthias Griese, Matthias Kappler, Helmut Ellemunter, (unknown), John Wilson, (unknown), Tony Velkov, Gauri G. Rao, Elena K. Schneider‐Futschik	15
16	Therapeutic Drug Monitoring Can Improve Linezolid Dosing Regimens in Current Clinical Practice: A Review of Linezolid Pharmacokinetics and Pharmacodynamics 2019 ·Therapeutic Drug Monitoring ·Gauri G. Rao, (unknown), Dario Cattaneo, Jan‐Willem C. Alffenaar, Deborah Marriott, Michael Neely	82
17	Definition and Validation of a Novel Metric of Erythropoiesis‐Stimulating Agent Response in Hemodialysis Patients 2018 ·The Journal of Clinical Pharmacology ·Calvin J. Meaney, (unknown), Benjamin M. Robinson, (unknown), Alan Forrest, Wojciech Krzyżański, Mandip Panesar, Gauri G. Rao	2
18	Assessment and modelling of antibacterial combination regimens 2017 ·Clinical Microbiology and Infection ·Gauri G. Rao, (unknown), Samira M. Garonzik, Roger L. Nation, Alan Forrest	20
19	Post-surgical mediastinitis due to carbapenem-resistant Enterobacteriaceae: Clinical, epidemiological and survival characteristics 2016 ·International Journal of Antimicrobial Agents ·Cely Saad Abboud, Jussimara Monteiro, Martín E. Stryjewski, (unknown), (unknown), (unknown), (unknown), (unknown), David M. Jacobs, Antônio Carlos Campos Pignatari, Carlos Roberto Veiga Kiffer, Gauri G. Rao	15
20	Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii 2016 ·International Journal of Antimicrobial Agents ·Gauri G. Rao, Neang S. Ly, (unknown), Alan Forrest, Jürgen B. Bulitta, Patricia N. Holden, Roger L. Nation, Jian Li, Brian T. Tsuji	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact